Clinicopathological significance of CXCR4 in non-small cell lung cancer

Clinicopathological significance of CXCR4 in non-small cell lung cancer

Xiao-ming Zhou,1 Lan He,2 Gang Hou,3 Bing Jiang,4 Yuan-he Wang,5 Li Zhao1 1Department of Respiratory Medicine, The Shengjing Hospital of China Medical University, Shenyang, People’s Republic of China; 2Department of Microbiology, The Chinese University of Hong Kong, Hong...

Full description

Bibliographic Details
Main Authors:	Zhou X, He L, Hou G, Jiang B, Wang Y, Zhao L
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-03-01
Series:	Drug Design, Development and Therapy
Online Access:	http://www.dovepress.com/clinicopathological-significance-of-cxcr4-innbspnon-small-cell-lung-ca-peer-reviewed-article-DDDT

Similar Items

Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
by: Xu L, et al.
Published: (2015-06-01)

Clinicopathological significance and potential drug target of T-cadherin in NSCLC
by: Wang Z, et al.
Published: (2014-12-01)

The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review
by: Wu X, et al.
Published: (2016-02-01)

Comments on a meta-analysis and systematic review of the clinicopathological significance of CDH1 in gastric cancer
by: Tu C, et al.
Published: (2016-03-01)

Clinicopathological significance and potential drug target of RUNX3 in breast cancer
by: Yu YY, et al.
Published: (2014-12-01)

Clinicopathological significance of non-small cell lung cancer with high prevalence of Oct-4 tumor cells
by: Chen Zhenguang, et al.
Published: (2012-02-01)

The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis
by: Liping Qiu, et al.
Published: (2022-06-01)

Clinicopathological Significance of <i>RUNX1</i> in Non-Small Cell Lung Cancer
by: Yujin Kim, et al.
Published: (2020-06-01)

Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.
by: Hiroaki Kasashima, et al.
Published: (2017-01-01)

Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis
by: Miao S, et al.
Published: (2015-07-01)

CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients.
by: Andrea S Fung, et al.
Published: (2021-01-01)

Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis.
by: Qingsong Wang, et al.
Published: (2020-01-01)

A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer
by: Zhang C, et al.
Published: (2015-06-01)

Clinicopathological significance and a potential drug target of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review
by: Song X, et al.
Published: (2016-04-01)

The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review
by: Chen Q, et al.
Published: (2015-09-01)

Analysis of Clinicopathologic Features of 9 Cases of  SMARCA4-deficient Non-small Cell Lung Cancer
by: Runan ZHAO, et al.
Published: (2022-08-01)

Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer
by: Kocdor H, et al.
Published: (2015-07-01)

Clinicopathological Analysis and Demographic Features of Ocular Malignancies
by: Al-Mujaini A, et al.
Published: (2021-01-01)

Small Molecule Inhibitors of CXCR4
by: Bikash Debnath, Shili Xu, Fedora Grande, Antonio Garofalo, Nouri Neamati
Published: (2013-01-01)

Design, synthesis, and antitumor evaluation of histone deacetylase inhibitors with L-phenylglycine scaffold
by: Zhang Y, et al.
Published: (2015-10-01)

Correlation of Immunohistochemical Expression of CXCR4 With Clinicopathological Characteristics of Invasive Ductal Carcinoma of Breast
by: Anahita Nosrati, et al.
Published: (2018-06-01)

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele
by: Yin J, et al.
Published: (2019-01-01)

Correlation between CXCR4, CXCR5 and CCR7 expression and survival outcomes in patients with clinical T1N0M0 non‐small cell lung cancer
by: Zhao Yue, et al.
Published: (2020-10-01)

Different Clinicopathologic and Computed Tomography Imaging Characteristics of Primary and Acquired EGFR T790M Mutations in Patients with Non-Small-Cell Lung Cancer
by: Hou D, et al.
Published: (2021-08-01)

CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
by: Andreas Krieg, et al.
Published: (2015-01-01)

CXCR4/CXCL12 Axis in Non Small Cell Lung Cancer (NSCLC) Pathologic Roles and Therapeutic Potential
by: Ori Wald, Oz M. Shapira, Uzi Izhar
Published: (2013-01-01)

Clinicopathological significance and potential drug target of p15INK4B in multiple myeloma
by: Li J, et al.
Published: (2014-10-01)

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer
by: Dubinett Steven M, et al.
Published: (2009-06-01)

Mutations in Non–Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications
by: Liu Yang, et al.
Published: (2023-06-01)

Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation
by: Andrea Ambrosini-Spaltro, et al.
Published: (2023-11-01)

Evaluation of Expression and Prognostic Significance of FUNDC1 Protein in Non-small Cell Lung Cancer Based on TCGA Database and Clinicopathology
by: WANG Yuxiu, et al.
Published: (2022-04-01)

Argyrophilic nucleolar organizer region in MIB-1 positive cells in non-small cell lung cancer: clinicopathological significance and survival
by: Dmitriy Sergeevich Kobyakov, et al.
Published: (2014-12-01)

The Expression of Caspase-3 and GRIM-19 in Non-mucinous Lung Adenocarcinoma and Their Clinicopathologic Significance
by: Handan Özdemir, et al.
Published: (2023-08-01)

Injectable long-acting systems for Radix Ophiopogonis polysaccharide based on mono-PEGylation and in situ formation of a PLGA depot
by: Shi XL, et al.
Published: (2014-11-01)

Clinical research progress of tumor mutational burden in EGFR-mutant advanced non-small cell lung cancer 
by: HE Xi, JIAO Xiaodong, ZANG Yuansheng
Published: (2021-01-01)

CENPF Promotes EMT in Non-small Cell Lung Cancer by Up-regulating ACKR3/CXCR7
by: GU Tong, et al.
Published: (2022-12-01)

Clinicopathological and Prognostic Significance of EML4-ALK Rearrangement in Patients with Surgically Resected Lung Adenocarcinoma: A Propensity Score Matching Study
by: Shi J, et al.
Published: (2020-01-01)

Associations of sirtuins with clinicopathological parameters and prognosis in non–small cell lung cancer
by: Gong J, et al.
Published: (2018-09-01)

Expression of CXCL12-CXCR4/CXCR7 chemokines in splenic fibrosis of cirrhotic spleen and its therapeutic significance
by: Yunfu Lv, et al.
Published: (2023-08-01)

Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis.
by: Yan-Long Yang, et al.
Published: (2014-01-01)